Dillman, R. O., McClay, E., Amatruda, T., Semeniuk, G., Haskins, C., Weber, R., . . . Cornforth, A. (2015). Superiority of dendritic cell vaccine vs tumor cell vaccine: Survival by stratification subsets in MACVAC randomized Phase II trial of patient-specific vaccines utilizing antigens from autologous melanoma tumor cell lines. J Immunother Cancer.
Citação norma ChicagoDillman, Robert O., et al. "Superiority of Dendritic Cell Vaccine Vs Tumor Cell Vaccine: Survival By Stratification Subsets in MACVAC Randomized Phase II Trial of Patient-specific Vaccines Utilizing Antigens From Autologous Melanoma Tumor Cell Lines." J Immunother Cancer 2015.
Citação norma MLADillman, Robert O., et al. "Superiority of Dendritic Cell Vaccine Vs Tumor Cell Vaccine: Survival By Stratification Subsets in MACVAC Randomized Phase II Trial of Patient-specific Vaccines Utilizing Antigens From Autologous Melanoma Tumor Cell Lines." J Immunother Cancer 2015.